Apr 12, 2024 / 12:00PM GMT
Operator
Thank you for standing by. My name is Jay, and I will be your conference operator today. At this time, I would like to welcome everyone to the OncoCyte fourth-quarter and year-end 2023 earnings conference call. (Operator instructions)
I would now like to turn the conference over to Jeffrey Ramson, PCG Advisory, Inc. You may begin.
Jeff Ramson - PCG Advisory Inc. - Investor Relations
Thank you, operator, and thank you, everyone, for joining us for today's conference call to discuss OncoCyte's fourth-quarter and full-year 2023 financial results and recent operating highlights. If you have not seen today's financial results' press releases, please visit the company's website on the Investors page.
Before turning the call over to Josh Riggs, OncoCyte's President and Chief Executive Officer, I'd like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. Any statements that are not historical fact are forward-looking statements.
We encourage you to review
Q4 2023 OncoCyte Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot